Ioannis Kokkoris, Professor of Law and Economics at Queen Mary University of London (QMUL), quoted in an article for Bloomberg: 'Syngenta Slumps on Concern of Protracted ChemChina EU Review'. “We have overlaps, no concessions have been offered: this will go to phase two,” said Professor Kokkoris, highlighting overlaps between Syngenta and ChemChina’s Adama unit that are "not a deal-killer."